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ABSTRACT 
H u man cy to tox i c  T l y m phocy t e  (CT L )  l ines w i th spec i fi c i t y  r e s t r i c t e d  for a u to logous  
squ amo u s  c e l l c a r c ino ma o f  the hea d  and nec k  (SCCH N )  w e r e  e s ta b l i shed from p e r i phe r a l  b l ood 
lymphoc y t es ( P B L )  ob ta ined at  the t i me of s u r g e r y  and a g a in at  two d i f f e r ent  t i mes a f te r  s u rgery  
f rom a p a t i ent  w i th canc e r  o f  the tong u e. The CTL l ines were  c u l tu red  in the p re sence o f  int e r l eu k in 
2 (IL2), inte r l e u k in 4 ( IL4) and a u to logous  t u m o r  ( A u T u )  c e l l  mono l ay e rs. A l l  three l ines  we re 
CD3 +cn8 +en 11 b-H L A -DR + T ce l l  r e c e p t o r  (TCR)a/fi+. The y we re  tested in 4h 51Cr- re l ease  assays  
aga ins t SCCHN ce l l  l ines (n=5)  and a v a r i e t y  of  non-sq u a m o u s  hu man t u m o r  (n= 5 )  and no r m a l  (n=5)  
cel l  t a rge t s  and  was  found to  l yse  onl y  AuTu ( PCI- 5 0)  and  three a l l ogene i c  SCCHN ce l l  l ines. Lys i s  
of A u T u  and  the three a l l ogene i c  SCCHN t a r g e ts by  the e s ta b l ished CTL l ines a p pe a r e d  t o  b e  MHC 
class I res t r i c ted,  s ince i t  wa s b l ocked  by  m onoc lona l ant ibod ies  to c las s  I MHC ant igens ( A gs). The 
CTL l ines p r o l i f e r a ted  in v i t ro  in re sponse t o  a u to l ogous  PCI-50  or an a l l ogene i c  SCCH N c e l l  l ine 
(PCI-1). The l ines ha v e  been ma inta ined in c u l t u re in the p resence of A u T u  mono l a y e r s  and r e t a ined 
cytoto x i c i t y  a ga ins t A u  T u  f o r  ove r  20  weeks .  
The AuTu (PCI-5 0 )  ce l l  l ine was te s ted  f o r  in v i t ro sens i t i v i t y to c y to t ox i c  o r  c y tos t a t i c  e ffects  
of v a r i o u s  e ff e c t o r  c e l l s, inc l u d ing the CTL l ines. PCI 5 0  t a r g e ts we re  r e s i s tant  t o  l ys is b y  r e s t ing 
hu man m ononu c l ea r c e l l s  b u t  sens i t i v e  to IL2-a c t i v a ted  na t u r a l  k i l l e r  ( A - N K )  c e l l s  in 4h 51Cr-re lease 
assays .  In c o m p a r i son w i th A-NK ce l l s ,  the CT L l ine m e d i a te d  lower l ev e l s  of  l y s i s  a g a ins t A uTu. 
Growth o f  P CI-5 0  ce l l s in c u l t u r e  wa s s i gni f i cant l y  inhibited b y  a comb ina t i on of interfe ron g a m ma 
(IFNI') and IL2  o r  by  high concent r a t i ons o f  t u mor  necrosis  fa c t o r  a l pha (TNFa). Whi l e  s u p e rna tants 
of A-N K c e l l s  were g rowth inhi b i t o ry, those  of the CTL l ine we re not. On the o ther hand , lys i s  of 
AuTu t a r g e t s  by the CT L l ine was  increased  by  p r e inc u b a t i on of the t u m o r  c e l l s  w i th TNFa or IFN)'. 
These  c y t o kines  a u g mente d  e x p res s ion of H L A-c la s s  I, HL A-c lass  II and int e r ce l l u l a r  a dhes ion 
molec u l e  I ( ICAM-I), b u t  not SCC-assoc i a t e d  Ags, E 7  and A 9 ,  on PCI-5 0  c e l l s. The CTL l ines d esc r i bed  
are  the f i r s t  wi th r e s t r i c t e d  spec i f i c i t y  f o r  a u to logous  SCCH N ever  r epo r te d  and the i r  a v a i la b i l i  t y  
w i l l  fa c i l i ta te s t u d ie s  o f  the A uTu T-ce l l  r e sponse i n  hea d  and neck  cancer .  
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INTR O D UCTI O N  
Squ a m o u s  ce l l ca rc inoma  of  the hea d a n d  nec k  (SCCH N) ce l l  l ines o r  f resh t u mor  ce l l s  
a re gene ra l l y r e s i s tant to  l ys i s  b y  non-a c t i v a ted  i mm une e f fec tor  c e l l s  s u ch a s  p e r i phe r a l  b lood  
na t u r a l k i l l e r  ( NK) c e l l s  o r  T l y m phoc y t e s  o b t a ined f rom norma l  v o l unt e e r s  (I). A lso,  f resh 
per i phe r a l  b l oo d  l y m phocytes  ( P B L), l y m ph nod e  l y m phocytes  ( L N L) o r  t u mor- inf i l t r a t ing 
l y mphocytes (TIL)  o b t a ined f ro m  p a t i ents wi th SCCHN have  not a b l e  to l y se  SCCHN ta rgets  
in 4h 51Cr- r e l ea se  a ssays  (2 -4).  H owe v e r ,  these  t u m o r  ce l l s  ha ve  been shown to  be  q u i t e  
sens i t i v e  i n  vitro to  1 y m phok ine-ac t i  va  t e d  k i l le r  ( L A K) c e l l s, I L 2 - a c t i  v a  t e d  human e f fec tor  
ce l l s, cond i t i oned media  of  A-NK ce l l s  ( 5) o r  c y t o k ines s u ch as  I L 2, IFNI' or  TNFa (6 ,7 ). In a 
nude  mouse  m o d e l  o f  hu man SCCH N, g r owth o f  the t u mo r  could be e f f e c t i v e l y  inhib i t e d  b y  
cytok ine-a c t i v a t ed  hu man e ffec tor  c e l l s  o r  the i r  so l u b l e  p r o d u cts  (5, 8 ). F u r ther more, w e  have  
recent l y  d e mons t ra t ed  tha t SCCH N a re ab le  to  a c t i v a t e  f resh o r  c u l t u red  hu man NK ce l l s  ( 5 ). 
As a r es u l t  o f  s u ch a c t iva t i on in vitro, NK c e l l s  we r e  shown to u p-r e g u l a t e  e x p ress ion o f  
ac t iva t i on A gs, l e v e l s  o f  m R N  A f o r  v a r i o u s  c y t o k ines, ant i t u mor  cy to to x i c i t y  and pro l i fe r a t i on. 
These resu l ts su gges t  tha t non-MHC- r e s t r i c t e d  i m m une re sponses  e l i c i t ed  b y  hu man SCCHN can 
p l ay  a majo r r o l e  in t u mo r  g rowth inhi b i t i on bo th in vitro and in v i v o, in  a nu d e  mouse  
x enogra f t  mod e l. 
The r o l e  o f  CTL in ant i t u mor  i m m une re sponse t o  SCCHN is no t known. A l though these  
tumors  a re gene ra l l y we l l  inf  i l  t r a  t ed  by  T 1 y m phoc y tes, i t  has  no t  y e t  been poss i b l e  t o  
demons t r a t e  the p resence of  A uTu-spec i f i c  CTL a mong the T I L, L N L  o r  P B L-T c e l l s  in p a t i ents 
with SCCHN. This i s  in cont ra s t  to pa t i ents w i th o the r t y pes  of  cance r, whe r e  the p resence of 
CTL spec i f i c  for A uTu in p e r i phe r a l  b l ood  or t u mo r  ha s been recent l y  d em ons t r a ted  in a 
var i e ty  o f  h u m an c a r c ino mas, inc l u d ing m e t a s ta t i c  m e lanoma (9, 1 0 ), o v a r i an cancer  (I 1, 12), 
rena l ce l l  ca r c ino ma  (13 ), ga s t r i c  cance r (1 4), g l i o b l a s t o m a  (15 ) or panc r e a t i c  c ance r  (16). These  
ant i t u mo r  CT L ha v e  been ma inl y CD3 +ens +TCRa/B+ and MHC-c l as s  I r e s t r i c t ed .  In 
me lano ma, and p e rha ps  in r ena l ce l l c a r c ino ma, ant i t u m o r- reac t ive  CT L a p pea r to  be impor tant 
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for successful  a d o p tive i m m uno t h era p y  ( A IT) w i t h  T I L  (17,18). In vitro a b il i t y  t o  lyse A uT u  
has been sh o wn t o  correla t e  wit h clinical responses t o  T I L  t h era p y  in p a t i ents w i t h  m e t ast a t i c  
melano ma (20 ). Fro m  previo us st u d i es, i t  is unknown w h e t h er SCCHN are su f f i c i ently 
i m m unogenic  to ind uce  a CTL response in vivo or w h e t h er i m m une T cells pla y any role i n  
resistance t o  t h e  gro w t h  o f  su c h  t u m ors. To t h e  best  o f  our knowledge, i t  h as no t been s o  far 
possible t o  genera t e  e f fec tor cells specif i c  for A uTu from ly m p h oid cells o f.p a t i ents with h e a d  
and nec k  c ancer. 
In t h is manuscript, we re port  t h e  generat ion and c h arac teriza t i on of CTL w i t h  
specif i c i t y  restr ic ted  t o  A uTu and a small nu mber o f  allogeneic SCCHN. Suc h  CTL could b e  
repea tedly genera ted  fro m t h e  per ip h eral blood o f  a pa tient wit h sec o f  t h e  tongu e, ind i c a t ing 
tha t t h e  CTL precursors were present in t h e  pa t i ent's periph eral blood for at least 2 y ears a f ter 
surgery .  O ur d a t a  indic a t e  t h a t  spe c i fic T cell responses to  A uT u  can b e  d e tec ted  in  a t  least 
some p a t i ents w i t h  SCCHN. 
MATER IALS A N D  METHODS 
Pa tient. T h e  p a t i ent was a 9 2-y e ar-old male w i t h  SCC of t h e  t ong u e  (T2 NOMO), w h o  
und erw ent p ar t i al glossec tomy a t  t h e  Uni versity o f  Pit tsburgh Medical Center, E y e  and Ear 
Hospital  ( Pit tsb urgh,  P A ). Histologically the  t u mor was a well differentia ted  SCC. 
P BL isola tion. P B L  of t h e  p a t i ent were isola t ed  by Ficoll-H ypaque  c entri f u g a t i on prior 
to surgery and t h en a t  two  o t h er tim es, a t  18 mont hs and 20· months, a f ter surgery. P B L  w ere 
exa m ined for v i a bili t y, counted 'and cryopreserved.  
Esta blishment o f  a u tologo us SCC cell 1 i ne (PCI-50). The  fresh t u m or specimen o b ta ined 
under s terile conditions was wash ed 3 times in Hanks' balanced salt solu t i on (Gi bco,  Grand 
Island, N Y) cont aining stre p tomycin (I 00 J.Lg/ ml), p eni cillin (I 00 IU / ml), and a m p h oter ic in B 
(I J.Lg/ml). Wash ed  t u m or tissue was  tri m med o f  fa t and necrot i c  rna  teria1 and f inely minced  
w i t h  scalpels in to  1 - to  2 m m3 fra gments in a sterile Pe tri dish (Costar, Ca m bri d ge, MA ). The  
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frag ments o f  t issu e  in t issu e  cult u re med i u m  (TCM) w e r e  t ransfe r red to  T2 5 t issu e  flasks and 
were  ma inta ined und istu rbed  fo r  1 w e e k  a t  3 7"C in a h u mi d i f i e d  a t mosp h e r e  of 5% C02 in a i r . 
The  TCM used was Ea gle's m ini mal essent i al med i u m  (MEM) su p ple mented  w i t h  1 %  ( v  / v )  
nonessent i al a m ino a c i d  m ixtu r e, 2 mM glu t a m ine, 1 00 Jlg/ml o f  st r ep tomyc in, 1 00 IU / ml o f  
penic illin, and 1 5% (v  /v )  f e tal  calf se r u m  ( F C S )  ( G i bco)  p r esc reened fo r  Mycoplasma and 
v i ruses. Flasks conta ining t u m o r  t issu e  f r a g m ents were  obse r ved  wee kly f o r  e v i d ence o f  
growth  i n  an inv e r ted -p h ase m i c roscope. F i b r o blasts o u tg r o w ing f r o m  explants w e r e  removed 
a t  weekly o r  b iweekly int e r vals, using a cell scr a p e r  (Costa r  No. 30 1 0) and "d i f fe rent i al 
t rypsiniza t i on" w i t h  0 .05% ( w  / v )  t r y psin (Gibco )  in 0.02% (w /v )  E DTA, as desc r i bed e a rli e r  ( 1 ). 
Cult u res of  cells w i t h  t h e  e p i t h el ial  m o r p h olog y  w e r e  extensi v ely wash ed w i t h  TCM follow ing 
each t r y psiniza t i on and inc u b a t e d  f u r t h e r  in t h e  p resence of TCM. T h e  cultu res w e re 
incuba ted  until  e p i t h eli al  cell m onola y e rs b e c a m e  confluent. They  were  t r y psinized a t  
conflu ence and spli t a t  t h e  1 :2 o r  1 : 3 c ell suspension:TCM r a t i o. Once esta blished,  t h e  P C I-5 0  
cell line w a s  ma int a ined i n  MEM su p plem ented w i th 1 0% ( v / v )  FBS, 2 m M  L-glu tamine, and 
ant i b i o t i cs (see a bove ) .  
Grow t h  o f  P C I -50  in nu d e  mice. A t h y m i c  B ALB/c  fe male 6 wee k-old m ice  w e r e  
ob ta ined f rom Taconic  Fa r m, Ge rmantown, N Y  and m a inta ined und e r  p a t h ogen-free  cond i t ions 
in t h e  ani mal fac ili t y. T h e  m i c e  w e r e  splenec tomize d 2 w e e ks before  t u m o r  injec t ions. One 
day p r i o r  to  inocula t i on of t u m o r  cells, all m i c e  were  injected int r a p e r i t oneally w i t h  
cyclo p h osp h a m i d e  (200  m g / k g; 4 mg/0 . 1 ml/m ouse, Siigma,  S t. Lou is, MO) and ant i-asi alo GM 1 
ant i bod y ( 1  0 m g / k g; 0 . 2  mg/0.2 m
'
l/ m o use, Wa k o, Dallas, TX). To esta blish t h e  t u mor, 5x 1 06 
PCI -50  cells w e r e  injected  su bcu taneously (sc) in t h e  r i g h t  flank o f  each  m i ce  in a g r o u p  o f  f i v e  
ani mals. T h e  t u mors w e r e  h a r vested 6 w e e ks a f t e r  injec t ion o f  PCI -5 0  cells and su b m i t t e� f o r  
h istolog i cally exa m ined. 
Gene r a t i on of CTL aga inst P C I - 5 0. T h e  pa t i ept's c r y o p rese rved  o r  f resh P B L  were  used 
as a so u rce  o f  CTL p recu rso rs. The cells w e r e  counted and checked  for v i a b ili t y  using t r y pan 
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b lue d y e .  T h e  l y m p h ocy tes w ere c u l t ure d in seru m- free A I M-V (Gi bco)  med i u m  in t h e  presence 
of I L2 ( 3 0 0  I U  / m l, C e t us Corp., E mery v i l l e, CA), I L 4  (300 U / m l, I m m une x Corp., Sea t t l e, WA), 
and PH A-P (5 J.Lg/ m l, S i g m a )  for 2 w e e ks in 2 4-w e l l  p l a tes (Costar). A f ter 2 weeks o f  primary 
cu l ture, PBL w ere co-c u l t ured e i t h er w i th a u to l ogous irra d i a t e d  ( 8,000 R ), w h i c h  were a d ded  
to c u l t ures once a w e e k, or  w i th v i ab l e  PC I -50 ce l ls a t  t h e  l y m p h ocy te  (L ) : t u mor (T) ra t i o  o f  5: 1 
in A I M-V med i u m  su p p l em ented w i t h  300  I U/ m l  of  I L 2  and 300  U/m l  o f  I L4 .  Fresh med i u m  
su p p l e ments w ere a d d e d  t w i c e  a w e e k .  I n  c u l t ures conta ining v i a b l e  t u mor ce l ls, PB L a p p e ared 
to grow w e l l  and w h en t h e ir nu mber w as grea ter t h an 3 x  106 / m l, l y m p h ocytes were transferred 
to a T-25 f l ask ( Costar) conta ining partia l l y  conf l u ent ( 3 0  to  50%) v i a b l e  t u mor ce ll  mono l a yers. 
The L:T ra t i o  w as ma int a ined  a t  5:1. C u l t ures were m oni tored for t h e  ce l l number, p h enot y p e  
and c y t o to x i c i t y  a t  re g u l ar interva ls. 
Genera tion of I L 2-ac t i  va  ted NK (A -NK) cells. A -N K  ce l ls w ere pre pared from 
allogene i c  PBL o b t a ined fro m  normal donors as pre v i o usl y descr ibed by  us ( 1 9) .  Bri efly, 
monocy te-d e p l e ted  PB L at a concentra t ion o f  5x 106 ce ll / m l  w ere inc u b a ted  in TCM conta ining 
6,000 I U/ m l  of riL2 (Ce t us) in p l ast i c  f l asks for 2 4 h .  At t h e  end of  t h e  inc u b a t ion period,  t h e  
p last i c-a d herent ce l ls w ere su p p l e mented  w i t h  TCM conta ining 6,000 I U  / m l  I L 2  and co-c u l t ured 
in the  presence of m i togen-prest i m u l a ted and irra dia ted  P B L  to  genera t e  a p o p u l a t i on h igh l y  
enric h e d  i n  a c t i v a t ed N K  ( A-NK)  ce l ls. Th ese c e l ls w ere m a inta ined i n  c u l t ure a t  a 
concentra t i on o f  1 .5-2 x  106 ce l ls/ml  by  su p p l y ing fresh TCM conta ining 6,000 I U  / m l  I L 2  as 
needed .  T h e  c e l l  c u l tures and su perna tants were harvested  b e tween d a ys 1 0  and 1 4  o f  gro w t h .  
Targe t ce l ls. In a d d i t i on t o  t h e  a u to logous SCCHN c e l l  l ine ( PCI -50), 4 a l logene i c  
SCCHN c e l l  l ines: PCI -1, - 2, - 4 A, -4 B  ( 1 ) , as w e l l  as K562, a c hronic  m y e logeno us l e u k e m i a  c e l l  
l ine; D a u d i, B c e l l  l y m p ho ma; L P  and S W, c h o l ang iocarc ino mas (20); H R, gastric  cancer ( 1 4 ); 
normal  f i brobl asts (n=2), and norma l  k era t inoc ytes (n= 3 )  were used as t arge t  ce l l s  for 
cy to to x i c i t y  assa ys. T h e  ce l l l ines were ma inta ined in c u l t ure as d escribed earlier (I) and 
passa ged b y  try psiniza t i on. 
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Cyto t oxi c i ty assa vs. Cyto toxi c i ty o f  P B L  a n d CTL was  d e termi ned  usi n g  4h 
m i n i a t urize d 51Cr-re lease assays as d escr ibed  earl i er (2 ). Brie f ly, 1x103 c e l l  targets l a be led  w i th 
5 1 Cr ( 5  J.LCi /m l; New E n g l a n d  N u c l ear, B os ton, MA)  were p l a ted  i n  tri p l i ca te  i n  we l ls o f  a 96-
wel l V-b o t t o m  p l a te (Costar) a n d  m ixed w i th e f fec tor c e l ls a t  E:T ra t ios ra n g i n g  from 2 5 :1 t o  
3: 1 .  Ce l ls w ere c e n tr i fuged  a t  1 0 0 0  rp m for 5 m i n  a nd i n cuba ted  for 4 h  a t  3 T C  i n  a C02 
i nc u b a t or. The a mou n t  o f  51Cr re l eased i n to the su pern a t a n t  (20  m l )  was  measured usi n g  a b e t a  
cou n ter ( L K B, Pharma c i a, Ga i thersburg, MD). Maxi ma l rad i o iso t o p e  re l ease w a s  d e term i ned  
i n  we l ls c o n t a i n i n g  targe t  c e l ls o n ly a f ter a d d i t i o n  o f  5% (v/v )  Tri t o n  X-100.  The perce n tage  
of  spe c i f i c  lysis was d e term i n e d  as: 
mea n experi m e n t a l  c p m - mea n spo n t a n eous c p m  
% spec i f i c  lysis = ---- - ----- ---- - - - - - -- -- - ---- --------------- ---- -------- - - - - - - -- - x 100 
m e a n  maxi m a l  c p m  - mea n spo n t a neous  c p m  
Lyt i c  u n i ts ( L  U )  o f  cyto toxi c i ty were ca  l eu I a t ed  accord i n g  to  the m e thod o f  Pross e t  a l  (21 ). 
One LU was d e f i n ed as the n u m ber of e ffec tor c e l ls requ ired for 20% lysis of 1x103 targe t  ce l ls, 
a n d  the n u rn  ber o f  I yt i c  u n i ts prese n t  i n  10 7 e f f ec tor c e l ls was ca l c u l a te d. 
I n  b l o c k i n g  experi m e n ts, CTL w ere pre i n c u ba ted  w i th v ari ous  concen tra t ions  o f  
a n  t i-CD3 ( L e u 4 ), a n  t i -CD8 (Leu 2a ), a n  t i -C D 4  ( L e u3a), a n  t i -C D 5 6  (Leu 1 9 ), a n t i -T C R  a/I3 (WT31) 
or mouse I g G  ( iso type co n tro l ), a l l  fro m B e c t o n  D ic k i nso n, Mou n t a i n  Vi ew, CA for 30 m i n  a t  
3TC be fore the ir a d d i t i o n  t o  51Cr- l a b e l e d  t arget  ce l ls. I n  so me cases, targe t  ce l ls were 
i nc u b a te d  w i th a n t i - H L A  c l ass I m A b  ( W6 /32, pro v i d e d  by Dr. O l ivera F i n n, P i t tsb urgh C a ncer 
I nst i t u te ); a n t i -H L A -D R  m A b  (obta i n e d  fro m Dr. Massimo Trucco, P i t tsburgh Ca n cer I nst i tu te); 
a n t i bo d i es a ga i nst SCC-assoc ia ted  A gs, A 9 (22 )  a n d  E7 ,  k i n d ly d o n a t e d  by Dr. Thomas Carey, 
Un i v ersi ty o f  Michi ga n (23), or E 4 8, U36, K 9 2 8, K 9 8 4  or K 93 1 a n t i bo d i es k i n d ly prov ided  by 
Pro fessor Gord o n  S now, Fre e Un i v ersi ty, A msterd a m, The Ne therla n ds (24 -26), before 
cyto toxi c i ty assays. I nhi bi t i o n  was c a l c u l a t e d  as: 
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% speci fic lysis i n  m Ab-·t r ea ted  we l ls  
% i nhi b i t i o n = 1 - X 100 
% specif ic lysis i n  co n tr o l  w e l ls 
I n  some e xpe r i m e n ts, PCI-5 0  ce l ls w e r e  i ncub a t e d  w i th 1000 U / m l  I FN 'Y ( B i og e n, Ca mb r idge, 
MA) o r  1000 U/m l  TNFa ( K n o l l  Pha r mace u t ica ls, Whippa ny, NJ) f o r  72h p r i o r  to  cyt o t o x ic i ty  
assays t o  e x a mi n e  the e f fects o f  cytoki nes o n  targe t  ce l l  suscept i b i l i ty t o  lysis by the CTL l i n e. 
-
Ef fects o f  Cytok i n es o r  Co nd i t i o n e d  Med i a  on Growth o f  the PCI -50  ce l l  l i n e . Effects 
of  v a r ious  cytoki n es on g rowth of  the PCI-5 0  ce l l  l i n e  w e r e  d e t e r m i n ed usi n g  a co l o r i me t r ic 
MTT [3 - ( 4, 5 - d i m e th yl thi azol -2 yl ) -2, 5-d iphen  yl t e t r azo l i  u rn  b ro m i d e ]  assay (2  7 ) .  B r i e f ly, 
d o u b l i n g  d i l u t i o n s  o f  each cytoki n e, a co m b i n a t i o n  of  cytoki n es o r  con d i t io n e d  med i a  f ro m  
CTL o r  A-N K  ce l l  cu l tu res w e r e  ob ta i n e d  i n  a 9 6  w e l l  f l a t -bo t tom pla te (Costa r), usi n g  TCM 
as d i l u e n t . T u m o r  ce l ls ( 5 x103/w e l l )  were  a d d e d  to  a f i n a l  vo l u m e  of 200 ;.d pe r w e l l. The pla te 
was i ncu ba ted  a t  3 7'C i n  a hu m i d i f i e d  a tm osphe re  of 5% C02 i n  a i r. O n  day 3 o f  cu l t u r e , 5 0  
;.d of  MTT sol u t i o n  (0 .5% w /v;  S i g ma)  w e r e  a d d e d  t o  each w e l l , a n d  the pla tes w e r e  i n  cu b a  t e d  
f o r  4h. Fo l l o w i n g  i ncu b a t i o n, supe r n a t a n t  (15 0  J..Ll )  w a s  r emoved  f r o m  each w e l l  a n d  r eplaced 
w i th 1 5 0  Jll o f  D MSO ( d i m e thyl su l fo x i d e; S i g m a )  to  d isso l v e  the fo rm aza n crysta l s. The pl a t es 
were p l ace d o n  a shaker  fo r  15 m i n  a n d  r e a d  i n  a p l a t e  rea d e r  ( Dyna tech L a b o r a t o r i es Inc., 
Cha n t i l ly, V A ), usi n g  a w a v e l e n g th of 5 7 0  n m .  R esu l ts f rom f o u r  w e l ls f o r  each d i l u t i o n  of the 
cytoki n es tested  w e r e  e xpressed as pe rce n t  co n t r o l  ± S D. 
Flow cyt omet ry. The phe n o type o f  f resh o r  cul tured l y mphocytes was d e t e r m i n e d  by 
two-co l o r  f l o w  cyto m e t ry as d escr i bed by us prev iously (2). B r i e f ly, ce l ls w e re adjusted t o  a 
co nce n t r a t i o n  o f  1 x 106 /ml  i n  PBS-0 .1% ( v /v )  sod i u m  azi d e  so l u t i on ,  a n d  0.2 m l  o f  this ce l l  
suspe nsi o n  was  i ncu ba ted  w i th 5 Jll o f  f l u o r esce i n - o r  phycoe rythr i n - l a b e l e d  m A bs a t  4'C f o r  
30 m i n .  The ce l ls w e re the n washed three  t i mes i n  P BS-sod i u m  azi d e  a n d  f i x e d  i n  2 %  (w /v )  
pa ra fo r m a l d ehyd e  so l u t i on  i n  P BS. Two-co l o r  a n a lysis was  pe r f o r med o n  F ACSca n (Becton 
D icki n so n ). The m A bs used were  purchased from B ecto n  Dicki nso n a n d  i ncl u d e d  the f o l l ow i n g  
speci f ici t i es: L e u 4  ( a n t i -CD 3), Le u2a ( a n t i-CD 8 ), Leu3a  (a n t i -CD4), L e u19 (a n t i -CD56), L e u15 
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(a n t i-CD l l  b ), a n t i - I L 2 R a  (a n t i -CD2 5), a nti - IL2RB ( p 7 5 ), a n t i -H L A / D R, a n t i -TCR a/13. As 
con t rols, mouse isotypes I g G I a n d  I gG2 w e re use d in a l l  e x p e r i m e n ts. T h e  m A b  to p 7 5  I L2 R  
was purch ased f rom E n doge n .  
I n  a d d ition, e x p r ession o f  H L A  Ags, ICAM-1 o r  SCC-associ a ted  A gs o n  PCI -5 0  ce l ls was 
exa m i n e d. The tumor ce l l  suspe nsions (2x 105 /tube) were f i rst i ncub a t e d  w i t h  5 1-d of a n t i-H L A  
class I ,  or  sev e r a l  conce n t r a t ions of o n e  o f  t h e  fol low i n g  m A bs: E 7, A 9, E 4 8, U36, K 9 2 8, K 9 8 4  
o r  K 931 a t  4'C for 3 0  m i n, washed, a n d  t h e n  i ncuba ted  w i t h  f luor esce i n-l a b e l e d  goat 
a n t i-mouse I g G  (TA GO, Burl i n game, CA)  a t  4'C for 30 m i n. F luor esce i n -con juga ted  
. a n t i - I C A M-1 ( A M A C, Westb rook, MA ) and  a n t i-HLA D R  m A bs (Becton D ic k i nson ) w e r e  a lso 
used i n  t h is study. 
Prolife ra tion assa v. P rol i fe rati ve responses of the  CTL l i n e  we re  e x a m i n e d  by 
co-cui tur i n g  104 · r espon d e r  ce l ls w ith i r rad ia ted ( 8 000 R) autologous P C I - 5 0  ce l ls ( a t  
respon d e r:st i mul a tor  r a t ios which ra ng ed f rom 1:1 to l : 8 ), a l loge n e ic tumor ce l ls or  nor m a l  
ke r a t i nocytes i n  96-w e l l  round - bottomed p l a tes a t  37'C for 3 d ays i n  A I M- V med ium 
sup p l e m e n t ed  w ith 300 I U/ m l  of IL2 a n d  300 U/ml of IL4. Th e ce l ls w e re pulsed w i t h  1 .uC i 
of [3H ]-thymid i n e  16 h be fore ce l l  h a r v est a n d 3[H]-thymid i n e  i ncorporation was  m easured.  
Sta tist ica I an a 1 ys is. The sig n i f ica nce of d i fferences b e t w e e n  e x pe r i me n t a l  a n d  con t rol 
g roups was  a n a lyzed usi n g  Stud e nt's t test or Wilcoxon's si g n e d  r a n k  test, as a p p rop r ia te. The  
l eve l  of si g n i f ica nce w as set  a t  p <0.0 5. 
RES ULTS 
Esta blishment a n d  cha racte ristics of the PC I--50 ce l l  lin e. PCI- 50  ce l l  l i n e  was 
esta b l ish e d  f rom f r esh SCCHN tumor exp l a n ts. Once est a b l ish ed, t h e  tumor ce l l  l i n e  g rew 
r a p i d ly (doub l i n g  t i me, 2 7.3h) .  I n  culture, the  PC I-50 l i ne  g rew as sha r p ly d e ma rcated, compact 
isl a n ds of ce l ls with a distinct e pith e lia l morphology (Fig. I a ). The con d ition ed  med ium of the  Fig .la 
ce l l  l i n e  conta i n e d  sma l l  amounts of p rosta g l a n din E2 ( PGE2 up to 6 pg/104 ce l ls) a n d  a l most 
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--no TGFI3 ( u p  to 0 . 03  pg/  104 ce l l s) .  H i stologic e x a m i nation of H & E sta i n e d  sections obta i n ed 
from the p ati e nt's tu mor show ed a we l l -d i ffe renti ated  sec, conta i n i n g  nume rous ke rati n ized 
epithe l ial  p e a r l s  ( F i g . l b). The tumor l i n e  was tu mor i ge n i c  i n  n u d e  m i ce .  Fol low i n g  a Fig .lb 
subcuta n eo u s  i njection of tumor ce l l s ( 5 x l 06 p e r  mouse), tu mors ( 7-10 m m  i n  d i a meter, 
V=250-3 0 0  m m3) d e ve loped  w ithi n  4 weeks. On  the othe r ha n d ,  these  tu mors g r e w  sub c uta ne-
ous ly i n  n u d e  m i c e  a n d  ha d a poorly-d i f fe re ntiated mor phology (F ig. l c) .  
G e n e ration of the CTL lines reactive  to PC I-50. To i n duce A uTu-reacti ve  e ffector ce lls, 
i r rad iated ( 5 000  R)  or  v i a b l e  tumor ce l l s  w e r e  co-i n c u b ated w ith P B L  obta i n e d  f rom the pati ent  
at  the r atio of  5:1 i n  A I M-V med ium in  the p resence of 300 I U/ m l  I L 2  and 300  U/ ml  IL4 .  The 
PEL obta i n e d  p r ior  to sur gery or those obta i ned at two t imes  a fte r su r g e ry a n d  cu ltu red  w ith 
i r rad iate d PCI-5 0 c e l l s  g e n e r a l ly stop ped g row ing  by week  5. Cryop reserved  f resh TIL d i d  not 
prol i f e r ate at  a l l . I n , contra st, PBL co-cultu red w ith non - i r r a d i ated v i a b l e  tu mor cell 
monol a ye r s  g r e w  e x  pon e  n tia II y, a n d the i r  cytotoxic i  1ty a g a i nst Au Tu conti n u ed to i n c rease .  
Fig .lc 
I n it ial ly, these  P B L  ha d high l eve l s  of cytotoxi city a g a i n st K 562 or  Da ud i a n d  showe d  no 
cytotox i c ity a ga i n st PCI- 50  ta r gets (F i g .2a) .  By wee k 6 in cultu re, the e f fector ce lls no lon ger  Fig . 2a 
lysed K 562  o r  D a u d i  ta r gets but ha d substa nti a l  a nt i -PCI-5 0  cytotox ic i ty. The CTL li n e  lysed  
PCI-5 0 c e l l s  ( e . g ., 1,2 9 5  L U20/ I 07 ce l l s, at week 10) and  was  ma i nta i n e d  in  lon g-te r m  cultu re  for 
ove r  20 w e e k s  i n  the p r esence  of v i a b l e  tu mor ce l l s, I L 2  a n d  I L 4. As show n i n  F i g .2b, by week  Fig . 2b 
10-12 of  c u ltu re ,  n e a r ly a l l  p rol i fe rati n g  c e l l s  were CD3+DR + a n d CDS+, whi l e  the p roportion 
of CD4 + T c e l l s w a s  l e s s  tha n 10%. How e v e r, by wee k 20, the CD4/CD8 ratio of cui tured  c e l l s  
shi fte d t o  a bout I ,  a n d  the CTL lost cytotoxic acti v ity. Whe n the same  patie nt's PBL w e r e  
obta i n e d  at  18  a n d  20  months afte r g lossectomy, CTL l i n e s  aga i n  were  g e n e r ated, w ith 
reacti v ity a g a i n st PCI-5 0 AuTu. These othe r CTL l i n e s  were  s i m i l a r ly stud ied  for phe notyp i c  
a n d  fun ctio n a l cha racte r i stics a n d  fou n d  to b e  id enti c a l  to the f i rst CTL l i n e. These  CTL l i nes  
a lso r eta i n e d  cytoto x i c  a ct iv ity aga i nst PCI-50 ta r gets for a bout 12  weeks  i n  c u ltu re .  No s ign  
of  tu mor r e c u r r e n c e  w a s  obse rved  in the patient d u r i n g  2 yea rs a fte r su rge ry. This  i s  of 
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interest, sin ce it indica tes tha t CTL precursors (CTL-p )  for a u tologous SCCHN were present in 
the b lood for a t  l east 20 mon ths in the a bse nce  of a l l  d e t e c ta b l e  tumor. I n  mixe d c u l t ures 
con taining  tumor c e l ls a n d  CTL, rose t t es of CTL surrounding the t u mor c e l ls w ere consistently 
observed at  2 4  hours a f ter tumor stimula tion ( Fig.3) .  The prese n ce of rose t tes in dica ted  tha t Fig . 3 
lym phoid c e l l s  w ere a b l e  to bind to AuTu c e l l s  in cul ture.  
Phenotypic a n d f u n c tional charact eristics of the CTL lin e. To d e t ermine phenotypic 
properties of the CTL lin es, f low cytome try studies were p erformed a t  various times in c u l t ure. 
As show n in Figure 2 b, the cul t ure esta b lished from P BL ob tained be fore surgery con tained 
more than 90% of CD3 +cos+ T c e l ls by week 6. At week 8, the phe notype of the CTL line w as 
CD3+ (99%), cos+co 1 1  b- (90%), TCR a/13+ (93%), HLA-D R  (90%), CD 56+ ( 7 2% ), CD25+ ( 5 2%), 
a n d  IL2 R p 7 5+ (93%). The prese n ce of IL2 R on SCCHN ce l l  l ines a n d norma l  k era tinocytes was  
d escribed by us  earlier ( 2 8 ). I n  con trast to  m a ny other SCCHN ce l l  lin es, which usua l ly express 
low l e v e ls  of CD25  ( 2 8 ), the l e v e l  of expression of CD25  ( the IL2 R-a chain)  on PCI-50 was 
consid era b ly gre a t er, a p proachi n g  tha t see n  on k era tinocytes in  primary cul ture (2 8 ). The CTL 
lines esta blishe d  su bseque n t ly (i.e., from P BL obtain ed  a t  1 8  a n d 20 mon ths a f t er surgery) a lso 
had the sa me phe notype a t  week  8 in  cul ture ( d a ta not shown). 
The origin a l  CTL lin e was tested in 4h 51Cr-re l ease assays a gainst SCCHN ce l l l in es 
( n=4)  a n d  a varie ty of non -squa mous huma n  tumor ( n==5 )  a n d  nor m a l  ( n= 5 )  c e l l  t arge ts b u t  w as 
found  to lyse on ly autologous SCCH N c e l l  l ine ( PCI-50, 4 8 2- 1 ,2 9 5  LU20/ 1 07 c e l ls) a n d  three 
a l loge n eic SCCHN ( PCI- 1 ,  -2, -4 B,:219, 1 32, or 1 4 1  LU20/I 07-ce l ls, respec tive ly, see Figure 4 ). Fig .4 
The CTL did not lyse a l log e n eic norma l  k era tinocytes ( n=3), fibrob lasts ( n=2 ), or a varie ty of 
non -squa mous c e l l  lin es tested: gastric carcinoma ( H R ), 2 chol a n giocarcinomas (SW and LP), 
K 5 6 2  or Daudi. Thus, our d a ta suggest tha t this CTL line proba b ly recog nizes a SCC-associa ted  
A g(s) expressed on autologous a n d a l logen eic SCCHN lin es. 
In ord er to be t ter d e fine  cytotoxicity of AuTu by the CTL line,  b loc kin g experime n ts 
with m A bs were p erforme d. I n c u ba tion of CTL with m A bs specific for the TCR a/13, CD3, C D 8  
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(Fi g.5 a )  or HLA c l ass I Ags (Fig .5b)  resul ted i n  dose-depend e n t  i nhi b i t i o n  o f  cyto tox ic i ty Fig. 5a 
agai nst  PCI-5 0, a n d  si m i lar resul ts were ob tained w i th PCI-1 targe t  c e l ls (data n o t  show n ). I n  
con trast, m A bs t o  CD4 or CD56 (F ig.5a) o r  t o  HLA-D R  or SCC-assoc ia t ed  A gs ( A 9  or E 7 )  d id 
no t  b l ock A uTu cyt o t o x i c i ty (Fig.5 b) .  Moreover, f i v e  add i t i o n a l  m A bs t o  SCC-assoc iated Ags Fig . 5b 
(E48, U36, K 9 2 8, K 9 84 or K931) also d i d  n o t  i nhi b i t  cyto to x i c i ty o f  the CTL aga i nst PCI-50 
(da ta n o t  sho w n ). These resul ts i n d ic a t e  tha t recog n i t i o n  of  an unkn o w n  Ag 9n auto logous and 
som e  a l l o g e n e ic t u m or ce l ls by CTL was MHC-class 1- restric ted an d i n vo l ved  the CD3-TCR 
comp l e x. H L A  typ i n g  i n d i ca ted that PCI- 50  shared B44, D R4, DQW3 A gs w i th PGI-4 ( A  and 
B re fer t o  c e l l  l i n es. est a b l ished from the primary an d recurre n t  tumor, resp e c t i ve ly). 
Un for tu nate ly, n o  HLA typ i n g  d a ta were ava i la b l e  for PCI- 1 or PCI-2 c e l l  l i n es. S tudi es are 
i n  progress w i th ad d i t i onal ce l l  l i n es to c o n f irm the HLA-restr ic ted  n a ture o f  the CTL l i ne-
SCCH N c e l l  i n tera c t i o n. 
To  determine whether the CTL lines also proliferated in response to tumor cells, 
eH]-thym i d i n e  i n corporat i o n  tests were performed. As show n  i n  F i gure 6, the CTL l i n e  Fig. 6 
esta b l ishe d from P BL o b ta i n ed prior to  surgery respon ded by dose-depe n d e n t  pro l i ferat ion  to 
PCI-5 0  ( 1 1 ,9 6 2  ± 1,742 c p m) and PCI-1 ( 5,418 ± 735 cpm)  but n o t  to e p i the l i a l  gastric  c a ncer ce l l  
l i n e, HR ( 1  , 544± 1 66 c p m), or  to n orm a l  kera t i n ocytes ( I  ,642 ± 152 cpm). The CTL had  a 
considerab ly  hi gher l e v e l  o f,respo nse to  auto logous tha n to a l loge n e i c  SCCHN l i ne. 
E f fec ts o f  cyt oki n es on suscept i b i l i t v of PCI- 50  targe ts to CTL or their supernatants. 
SCC H N  c e l l  l i n es ha v e  been  show n  by us earl ier to  be NK -c e l l  resista n t  but sensi t i ve to 
lymphoki n e -a c t i  va ted  ki l l er (LA K) c e l ls in 4h 51Cr-re: l ease assays (27) .  The data prese n ted i n  
Tabl e  1 d e m onstrate tha t PCI-50  t argets  were resistant t o  rest i n g  N K  c e l ls ( n ormal MNC), but Table 1 
very se n si t i ve to  IL2-a c t i v a ted adhere n t  N K  (A-N K) ce l ls a n d  tha t the CTL l i n es we  estab l ished 
se l e c t i v e ly lysed auto l o gous tumor but n o t  K562  or Daud i targe ts. I n  our pre v i ous e x per iments, 
we o bserved  tha t lysis of  SCCHN targets by n o n-�1HC-restr ic ted  e f fector c e l ls was of ten  
i n crease d i n  vitro by pre i n cubat i o n  o f  the tumor c e l ls w i th exogenous cyto k i n es ( 5 ) . To  
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de term i n e  i n  vitro e ffec ts of various cytok i n es on PCI-50 suscep t i b i l i ty to lysis by CTL l i nes, 
we n e x t  pre i n cubate d  these targe ts w i th various cytok i nes or m i x tures of cyto k i nes be fore 
cytotox i c i ty assays. As show n i n  Tab l e  2, pre i n cubation of PCI-5 0  targe ts w i th 1,000 U/ml  of Table 2 
IFN-y, 1,000  U/m l  of  T N Fa or a com b i nat ion of the two cytok i n es for 3 days prior to 51Cr-
rel ease assays s ig n i f i ca n t ly i n creased ( p <0.0 5 )  lysis of PCI-50 targets by the CTL. Such 
pre i n cubat ion was show n to be assoc iated w i th i ncreased e x pression of certai n surface 
molecules on PCI-5 0 (F ig . 7 ). Whi l e  IFN-y si g n i f ican t ly i n creased e x pression of c lass I -MHC Ags Fig . 7 
and ICAM- 1 ,  TNF a pri mari ly upregula ted  ex pression of c lass I an d c lass II MHC A gs (F ig .7) .  
A com b i nat ion of  these two cytok i n es i ncreased ex pression of al l three types of surface Ags; 
however, an  ad d i t i ve effec t  was observ ed  on ly for c lass II  MHC molecul es (F ig . 7 ) .  Pre treatmen t  
of  PCI-50 w i th I FN-y was consist e n t ly more effec t ive  i n  augme n t i n g  lysis of  PCI-50 targe ts by 
CTL l i ne than T N F  a (Tab le  2). N e i ther the two cytok i nes nor the ir com b inat ion i n creased 
expression of SCC-associated Ags, E7 or A9, on PCI-50 targets (data not shown). 
I n  ad d i t io n  to i n creasi n g  tumor ce l l  se nsi t i v i ty to lysis by i m mune e f fec tor ce l ls, 
cytok i n.es hav e  b e e n  shown to med iate cytostat i c  effec ts on SCCHN c e l l  l i n es ( 7 ). PCI-5 0  ce l l  
l i n e was not  i nhib i te d  in  grow th by I FN-y, low con c e n trat ions (<2,000 U/m l )  of  TNFa or 
supernatan ts of the CTL l i nes (F ig . 8 ) .  A l though the tumor c e l ls e x presse d the IL2Ra and Fig .Sa-c 
IL2RB, IL2 d i d  not  i nhi b i t  the ir grow th over a w i d e  ran ge of conc e n trat ions t es ted  ( data not 
shown ) ,  as d e monstrated  by us for other SCCHN targets (28) .  However, whe n a comb i nation 
of I FN-y and IL2 (22 n M) or supernatants of A-NK ce llls, k now n to con tai n si g n i f ican t l evels 
of I F N-y and IL2 (5)  were tested ,  grow th of PCI-50 was si g n i f i can t ly i nhi b i t ed  ( F i g . 8a and c) .  
S i m i l arly, hi gh con c e n trat ions of TNFa had profound grow th- i nh ib i tory e ffects on  PCI -50  ce l ls 
i n  vitro. 
These e x p er i m e n ts i n d icated  that pre incubation of PCI-50 targe ts w i th comb i nation 
cytoki n es or certai n e ffector ce l l  supernatan ts could either al ter the tumor c e l l  se nsi t i v i ty to 
lysis, i nhi b i t  tumor growth or both. A lso, d irect  i n teract ion of the CTL l i ne w i th autologous 
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t u m or c e l ls a p peared t o  be  necessary for its a n t it u mor a c t iv i ty ,  a n d  CTL su p erna t a n ts were n o t  
cytost a t ic o r  c y to to x ic for A uT u  in v itro . 
D ISCUSSI O N  
H a llmarks of a T  cell respo nse to ,  e .g . ,  t u m or-associa ted Ag(s) ( T  A A )  are its spe c ific i ty  
and imm u n o l o g ic memory. T h e  c y t o t o x ic CD8 + T cell recogn izes A gs ! hro u g h  the  T -ce l l  
recep tor (TCR) in  assoc ia t io n  w ith  a restric t io n  ele m e n t  o n  t h e  H L A  c l ass I p e p t ide  (29 ). The 
resu l t  of su c h  reco g n it io n  is a sig n a l  for a c t iv a t ion ,  cy to k in e  pro d u c t io n ,  a nd e x pa nsion of a 
T ce l l  clo n e ,  w it h  c o n c o m it a n t genera t io n  of memory T l y m phocy tes (30) .  I t  h as been u n cer ta in 
to w h a t  e x te n t  A gs o n  h u m a n  so l id t u m ors are immu n og e n ic for in d u c in g  specific CTL 
responses. AI t h o u g h  CTL w it h  ••specific i t y11 for A u  Tu h a v e  been ob ta in e d  fro m periph era l 
b lood or T I L  i n  so me p a t ie n ts w ith  so l id t u m ors, in most p a t ie n ts, it has  n o t  been  p ossib l e  t o  
doc u m e n t  t h e  prese n ce o f  su ch  T cells in  t h e  p eriphery o r  at t h e  tumor site. Also, rigorous 
st u d ies t o  c o nf irm A u T u  spec ific i ty  of CT L are d iffic ult in h u ma ns, as A uTu ce l ls, l arge p a n els  
of a l l oge n e ic t u m or ce l ls  as well as n orm a l  ce l l  t arge ts are not  rea d il y  a v a il a b le. I t  has  b e e n  
sug gested  t h a t  qu a n t i t a t ive  ra t h er t h a n  qu alit a t iv e  a n t ig e n ic c h a n ges, w h ic h  occur o n  t h e  
surface  o f  t u m or ce l ls, m a y  n o t  be  recog n ized as 11n o n·-se lf11 by  the  im m u n e  syste m  (3 1 ) .  For t h is 
reaso n ,  in v iv o  d e v e l o p m e n t  of CTL w it h  A u T u  specific i ty  m a y  be a rare e v e n t. A lso, som e  
t u m ors m a y  pro d u c e  imm u n osu p pressive fa c tors (32) ,  w h il e  o t h ers ma y be  associa ted  w it h  a 
defe c t iv e  A g-prese n t in g  p a t h w a y  (33), t h us pre v e n t in g  ge nera t io n  of effec t ive  imm u n e  
resp onses. I n  t h e  case o f  SCCH N, h u m ora l respo nses to  T A A  h a v e  b e e n  d e m o nstra ted  a n d  
st u d ied  e x t e nsiv e l y  ( 2 2-26) .  Mon o c l o n al a n t ibod ies t o  T A A  h a v e  been  prod uced ,  a n d  i n  so m e  
cases, t h ese m A bs h a v e  bee n sh o w n  to recog n ize a u n ique A g  (e .g., K93 1 )  n o t  prese n t  o n  n orm a l  
squ a mous  e p it h eliu m.  I n  con trast,  specific T-ce l l m e d ia ted responses to  a u t o l ogous SCCHN 
h a v e  b e e n  d ifficult to  d e m onstra te ,  alt h o u gh a large body of e v idence e x ists for t h e  a b i l it y  of 
t h ese t u mors t o  in d u ce n o n-MHC-restric ted  effec tor mec h a n isms both in v ivo  a nd in v itro ( 2,4) . 
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I n  t his m a n uscript, we  h a v e  d escribed t h e  g e n era tio n a n d  properties of A uTu-rea c ti v e  
CTL lines o b t ained  fro m P BL o f  a p a tie n t  wit h S C C  o f  t h e  t o n g u e. T h e  o n e  in triguin g aspec t  
of t h e  process of CTL g e n era tio n has  been  tha t  a l l  t hree a t t e m p ts a t  esta b lishin g a CTL lin e  
fro m t his p a tie n t's P B L  o v er a p eriod  o f  20  m o n t hs h a v e  b e e n  successfu l .  I n  c o n trast, w e  h a v e  
fai led  to  est a b lish CTL fro m  P B L  o f  1 0  o t h er in divid u a ls with SCCHN for w h o m  A uTu ce l l  
lin es a n d  cryo preserved P BL were a vail a b l e, u tilizin g t h e  sa m e  e x p erim e n t a l  c o n ditio ns. These 
in divid u a ls eit h er h a v e  recurre n t  disease or h a v e  die d  of disease. T h e  a bilit y to repea ted l y  
genera te  CTL lin e fro m this pa tie n t's P BL in dic a t es t h a t  CTL precursors (CTL-p )  h a v e  b e e n  
prese n t  in t h e  periphera l circ u l a tio n o f  t his in divid u a l ,  a n d  t h a t  in t h e  prese n ce o f  t h e  A u T u  
ce l l lin e ,  t h ese CTL-p h a ve b e e n  a b l e  to pro lifera te a n d d e v e l o p  in to  c y to toxic effector ce l l s. 
The p a tie n t , w h o  was surgica l l y  trea ted ,  has  n o t  rela psed in more t h a n  2 y ears fo l l owin g 
surgery a n d  remains in good hea l t h  in spite of a n  a d va nced  a g e  of 9 2  years. C learl y, t h is 
pa tie n t  has h a d  a stro n g  a n t i t u mor im m u n e  respo nse. In co n trast, we  were u nab l e  to estab lish 
a CTL lin e fro m cry opreserved TIL ob t ain ed fro m t his pa tie n t's t u mor a t  t h e  time of surgery. 
This mig h t  be  d u e  to u nfa vora b l e  in vitro con ditio ns .in c l u din g co nsid era b l e  c o n t a mina tio n of 
TI L wit h A u T u  c e l ls or prod u c tio n by t h e  tu mor of im m u n oin hibitory fa c tors responsib l e  for 
poor TIL pro lifera tio n in vitro. Eve n  t h o u g h  PCI -50 su pern a t a n ts c o n tain ed o n l y  l ow l e v e ls 
of PGE2 a n d n o  TGFn, o t h er im m u n oin hibitory fa c tors mig h t  d o w n -reg u l a t e  TIL respo nse t o  
IL2 (34) .  A lso , l ev e ls o f  im m u n oin hibitory fa c tors prod uced  i n  vitro b y  PCI-50 l i n e  mig h t  n o t  
refl ec t  l e ve ls o f  t h ese fa c tors prod uced  i n  viv o. 
T h e  n a t ure of a n  Ag(s) respo nsib le  for t h e  TCR-media ted  re cog nitio n of AuTu c e l ls b y  
o ur C T L  lin es is u n k n o w n. We h a v e  a t tem pted to  use a se l e c tio n of a vail a b l e  a n ti-SCC m A bs 
for in hibitio n of A uT u  c e l l  l ysis by  t h e  CTL to  o b tain informatio n a bo u t  t h e  A g(s) t h e  CTL 
recog nize. H o w e v er, n o n e  of t h ese rnA bs, e.g., to  A 9  in tegrin a6n4 (22)  or to  the E7 A g, w h ose 
e x pressio n o n  t u mor c e l ls m a y  be re l a ted to t h e  chro m oso me 1 1  rearra n g e m e n t  in sec (23), were 
a b l e  to  b l o c k  l ysis of A u T u ,  P CI-50, by  the CTL lin es. A series of m A bs, £4 8, U36,  K928, or 
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K984, w h ich  reco g n ize squ a m ous ce l l  e p it h e l ia l  A gs o n  both  n orm a l  a n d  t u mor e p it h e l ia ( 24-26)  
were a lso tes ted  and  found i n e f f e c t ive  in  b l oc k in g  e x perimen ts. Beca use the  CTL l in es h a d  
stro ng l y t ic a c t iv it y  a ga inst A u T u  a n d  3 a l l o g e n e ic SCCHN,  b u t  n o t  a ga inst o t h er carc in o mas 
tested so far or n orma l  k era t in o c y t es, i t  a p pears t h a t  t h e  CTL reco g n ize an Ag w h ose 
distrib u t io n  is restric ted  to som e  SCCHN c e l l  l in es. S u c h  a restric ted d istrib u t ion  of t h e  
ant ige n ic e p it o p e , wh ich presu ma b l y  is recog n ized by  t h e  T C R  in associa t io n  with a c l ass I 
MHC Ag,  su g gests t h a t  it is a c o m m o n  e p it o p e  sh ared by certa in SCCHN b u t  no t  by  n orma l  
epi the! ia I ce l ls. S t u d ies are i n  pro gress t o  d e term in e bo th  t h e  id e n t it y  o f  t h e  MHC restric t in g  
eleme n t  a n d  b io c h e m ic a l  n a t ure o f  t h is A g. 
A l t h o u g h  in tera c tio ns b e t w e e n  A uTu a n d  CTL are d e p e n d e n t  o n  t h e  TCR-media ted  
recogn i t io n  o f  a p u  ta  t i  ve  t u  mar Ag, o t h er surface  m o l e c u l es a ppear to  be in val ved  as wel l . For 
examp le ,  pre in c u ba t io n  o f  P CI-50 targ e ts with  TNFa or IFN-y increased ex pression o f  
HLA -class I ,  H L A-c l ass I I  a n d  IC AM-1 b u t  n o t  t h e  SCC-assoc ia ted A gs, E 7  o r  A 9. A t  t h e  sa me 
time, su ch  pre in c u ba t ion  wit h c y to k in es a lso sig n if ica n t l y  in creased susc e p t ib il ity  of  A uT u  t o  
lysis by  t h e  CTL l in e .  Th us, t h e  a d d it ion  o f  c y t o k ines to  t h e  tu mor in vi tro a n d t h e ir a b il it y  
t o  mod u l a te e x pressio n o f  surface  m o l e c u l es o n  t u m or targe t  c e l ls c l earl y con trib u tes t o  
a n t itu mor e f fec ts med ia t ed by  t h e  CTL. In a d d it ion  to a u g m e n t ing  se nsit iv i ty  of  t umor ce l ls 
to l ysis by CTL,  c y to k ines may a lso med iate cy tosta t ic e f fec ts, a n d  in t h e  case of  PCI-50, a 
combin a t ion o f  IFN -y a n d  IL2 as w e l l  as TNF a a t  conce n tra t ions  h igher t h a n  I 000 U / m l  were 
ab le  to in h ib it t u mor growth in v itro. In c o n trast to c u l t ure su pern a t a n ts of h u ma n  a l l oge n e ic 
NK ce l ls, su p ern a t a n ts o f  t h e  CTL were n o t  gro w t h  in h ib itory for PCI-50 c e l l  l ine. T h is 
observ a t ion  su ggests t h a t  d irec t  c o n t a c t  o f  t h e  CTL w it h  A uTu targets is essen t ia l  for 
activa t io n  of CTL a n d t h e ir a n t it u m or e f fec ts, as a lso demo nstra ted by bo th  rose t te  forma t io n  
a n d  pro l ifera t io n  i n  t h e  prese n ce o f  A u T u . O u r  pre l im inary observa t ions regard in g i n  v itro 
effects of c y t o k in es a n d ce l l u lar su pern a t a n ts of e f fector c e l ls on growt h or susce p t ib il it y  to  
lysis of  PCI-50 targe ts pro v ide  a basis for f urther st u d ies o f  t h ese e f fec ts in v ivo. 
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P r e v io us r esu l ts from o u r  l a b o r a t o r y  ind icated t h a t  immu n o t h e ra p y  of SCCHN w i th 
effec t o r  c e l ls a n d / o r  c y t o k ines such as I L 2  o r  I FNI' o r  su p e r n a ta n ts of A - N K  c e l ls m a y  be  
effe c t iv e  in t h e  co n t ro l  of  t u mo r  g r o w th and  l e a d  t o  reg ression of est a b l ished t u mo r  in a 
xenog raft m o d e l  of SCCHN in n u d e m ice  (5, 7 , 8 ) . T h e  a v a il a b il it y  of t h e  A uT u  c e l l  l in e ,  PCI-50,  
as w e l l  as spe c ific ( t h e  CTL l ines) a n d  n o n -spec ific ( A-NK ce l ls) effec to r  ce l ls a l l ows us  to  
com pa re  t h e ir a n t it u m or  a c t ivi t ies first in  vit ro  a n d l a te r  in vivo, in  t h e  �en o g raft mode l  of 
SCCH N in n u d e  m ice est a b l ish ed in o u r  l a b o r a to ry  (5, 7 , 8 ). T h is c o m b in a t io n  of 
w e l l-c h a r a c t e r ized effec tor  ce l ls sh o u l d  fa c il it a t e  fu r t h e r  stu d ies of t h e  mecha n isms i n vo l v ed 
in effec to r - t u mor  t a rge t  in t e rac t ions  a n d p ossib l y  l e a d  to  id e n t ifica t io n  of t u mo r  A gs which 
initia te a n d sustain th ese intera c t ions. Unde rsta n d in g  of t h ese mec h a n isms is im por t a n t  fo r 
fu t u re d e v e l o p m e n t  of n o v e l  t h e r a p e u t ic a p p roaches fo r SCCHN, a r e l a t iv e l y  common c a n ce r  
wit h  sig n ifica n t  m o r bidity a n d  v e r y  h igh  ra tes o f  recu r re n ce ( 3  5) w h e n  t re a t e d  w ith 
c o n ve n t io n a l  t h e r a p y. 
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Ta ble  1. Lys i s  o f  the  SCCHN cel l l i n e  (PCI-50)  
b y  immu ne effec t o r  cel l sa 
E f fec tor  cel ls 
Ta r get cel l s  Res t i n g  MNC A-NK cel l s  C T L  l i neb 
K 5 62 153  ± 7 2  5 8 6 3  ± 8 7 2  4 ± 4 
D a u d i  9 ± 3 314 2 ± 4 5 6  ± 
PCI-5 0  9 ± 4 2 3 6 9  ± 5 8 0  112 5 ± 2 2 8  
a C y t o t oxi c i t y  d a ta ( 4 h  51C r-relea se as says )  a re mea n s± S D  o f  l y t i c  
u n i t s (LU20/107 effec t o r  cel l s) f rom t h ree experimen ts.  
b T he CTL l i ne tes ted was es ta b l i s hed f rom PBL o b t a i ned p r i o r  to 
surger y. 
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Ta b l e  2 .  E f fec t s  o f  c y t o k i nes  o n  susce p t i b i l i t y  o f  PCI -50  SCCHN c e l l  l i n e  
to  l y s i s  b y  t h e  C T L  l i n e 
Trea tme n t  
N o n e  
TNFa ( 1 000 U/m l )  
IFN 'Y ( 1 000  U/ml ) 
TNFa + IFN'Y 
L y t i c  un i ts 
( L U20/I07 ce l l s )b 
8 5 3  ± 3 1  
1 096  ± 1 30* 
1 624  ± 2 1 9* 
1 26 6  ± 2 5 4* 
a PCI - 5 0  ce l l s  were i n cuba ted w i t h  med ium o r  c y to k i n es  f o r  3 d a ys p r i o r  to  c y t o to x i c i t y  as says .  
Tumor ce l l s  w e r e  washed  a n d used a s  t a r ge ts in  c y t o t o x i c i ty as says .  
b C y t o to x i c i t y  d a ta ( 4 h  51Cr - r e l ease  a ssa y)  a re mea n s ± S D  f rom t h ree  e x pe r ime n t s. T h e  CTL 
l i ne es t a b l i s h ed f rom PBL ob ta i n ed be fore surg ery was  used .  
* p < 0.0 5 ,  s t a t i s t i ca l l y  s i g n i f i ca n t  d i f fere nce  i n  c y t o t o x i c i t y  o f  PCI - 5 0  t a r g e t  i n cuba ted  w i t h  o r  
w i t h out c y t o k  i n es .  
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LEGENDS 
F i g u re 1 .  
F i g u re 2 .  
F i g u re 3.  
F i g u re 4. 
F i g u re 5 . 
-- ----- --
( A )  Mi c roscop i c  c h a ra c t e r i s t i c s  o f  PCI -50  l i n e,  w h i c h  g ro w s  a s  a compact  
m o n o l a ye r , Ma g x 3 1 5 ; ( B )  h i s to log i c  s ec t ions  o f  t h e  o r i g i n a l  t u m o r  removed a t  
t h e  t i me o f  s u r g e r y  a n d  s t a i n ed w i t h  h e m a t o xy l i n  & eos i n  ( H&E)  Mag x 3 1 5 ; (C)  
h i s t o l o g i c  sec t i o n s  o f  the  t u m o r  es ta b l i shed  b y  a s u b c u t a n e o u s  i njec t i o n  of  
P C I - 5 0  ce l l  l i n e  d e r ived  from t h i s h u m a n  t u m o r  (H&E) Mag_ x 3 1 5. 
C h a n ges i n  c y t o to x i  c a c t i v i t i e s  a g a i ns t  K 56  2 ( --0-), D a u  d i ( - .t.-) o r  PC I -5 0  c e 1 1  s 
(-0-) o f  P BL co-c u l tu red  w i t h  A uTu i n  t h e  p resence  o f  IL2 a n d  IL4 (A) .  I n  (B ), 
c h a n ges i n  t h e  p h e n o t y pe d u r i n g  c u l t u re o f  these P BL a re s h ow n. P BL w e re 
ob ta i n ed f r o m  t h e  p a t i e n t  b e fo r e  su rgery .  
Rose t t e  for m a t i o n  be tween  PCI -5 0  c e l l s  and  the  CTL l i n e  e s ta b l i shed  from P BL 
o b t a i  ned  f r o m  t h e  p a t i e n t  b e f o re su rgery .  Rose t tes were  u s u a l l y  o bserved w i t h i n  
24-4 8 h  o f  co-cu l t u r e  o f  t h e  CTL w i t h  a v i a b le  lPCI -50  monol a y e r. Roset tes  s h o w n  
w e r e  p h o t o g r a p h e d  a f t e r  4 8 h  o f  co-c u l tu re .  1vfag  x 6 3 0. 
Cyto to x i c i ty o f  t h e  A uT u -r e a c t i v e  CTL l i n e  ( 1 0-week  c u l t u r e ) .  Cytoto x i c i t y  
a g a i n s t a pa n e l  o f  t u mo r  o r  n o r m a l  ce l l  t a r g e ts was  exa m i n ed i n  4 h  5 1 Cr-re l ea se  
a s says. T h e  d a ta a r e  f rom o n e  o f  t h ree  e x p e r i me n ts p e r f o r m e d. 
I n  h i  b i  t i o n  by  v a r i ous  rn A  b o f  c y to tox i c i t y  m e d i a  t ed  by  t h e  CTL l i ne  aga i n s t  
P C I - 5 0  t a rge t s .  I n  ( A ) ,  CTL w e r e  p r e i n cu ba t e d  w i t h  0 . 1 -2 Jlg/ m l  o f  a n t i -CD3 ,  
a n t i -CD4 ,  a n t i -C D 8 ,  a n t i -CD 56 ,  a n t i -TCR a/B, o r  i so type  co n t r o l  a n t ibod ies  fo r  
30  min  p r io r  t o  4 h  5 1 C r - r e l ea se  a s says .  I n  ( B ), PCI -50  c e l l s  w e r e  p r e i n c u b a te d  
w i t h  d i l u ted  ( f i n a l  d i l u t i o n ,  2 : 1 to  1 6 ; 1 )  a n t i -HLA c l a ss I ,  a n t i -HLA c l a s s  I I ,  o r  
a n t i bo d i es fo r  t h e  SCC-a ssoc ia ted Ag  (A9  o r  E7 )  f o r  30  m i n  a n d  t h e n  u s e d  a s  
t a rge t  c e l l s  i n  c y toto x i c i ty a ssa ys .  The  d a ta a re f rom a r e p re se n t a t i ve e x p e r i ­
m e n t  o f  t h ree p e r formed. 
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F i g u r e  6 .  
F i g u re  7 .  
F i g u r e  8 .  
P r o l i fe r a t i o n  o f  t h e  CTL l i n e i n  re sponse  to  PCI - 50  o r  a l l oge n e i c  t u mo r  c e l l s . 
T h e  C T L  l i n e  ( 1  x 1 04/we l l )  was  i n c u ba ted i n  t h e  p r esence  o f  IL2 a n d  I L 4  a n d  
i r r a d i a ted a u t o l ogous  o r  a l l o g e n e i c  t u mors  f o r  3 d a ys .  T h e  t u mo r  ce l l :CTL r a t i os 
r a n ged  f r o m  1 : 8 to  1 : 1 .  3[ H ] t h ym i d i n e  i n corpo r a t i o n  was  m e a s u r e d  f o r  1 6h p r i o r  
t o  h a r v es t .  A n  a s t e r i s k  i n d ica tes  a s i g n i f i ca n t  dl i f f e r e n ce ( p <0 .0 5 )  compa red  w i t h  
CTL i n  m ed i u m  a l o n e .  
E x p re ss i o n  o f  t h e  H L A  a n t i g e ns ,  I CA M- 1 a n d  S CC-assoc i a t e d  a n t i ge n s  on  PCI-50  
ce l l s  in  the  p rese n ce o f  c y to k i n es .  PCI -50  ce l l s were  i n c u b a t e d  f o r  7 2 h  in  t h e  
p re s e n c e  o f  med i u m ,  TN Fa, I FN'Y o r  bo th  c y t o k i nes  a n d  t h e n  e x a m i n ed f o r  
e x p re ss i o n  o f  t h e  H L A  a n t i g e n s , I C A M- 1 ,  A 7 o r  E7  by f l o w  c y t o m e t ry .  Absc i ssa,  
r e l a t i v e  f l u o resce nce i n te n s i t y  ( l og  sca l e ) ;  o r d i n a te ,  r e l a t i v e c e l l  n u m b e rs ( l i n ea r  
sca. l e ) .  T h e  a s t e r i s k s  i n d i c a t e  a s i g n i f ica n t  ( p <0 .05 )  sh i f t i n  mea n f l u o rescence  
i n te n s i t y  (MFI ) f rom tha t  in  me d i u m  con t ro l .  
E f fec t s  o f  I FN'Y (----) o r  I F N'Y p l u s  I L 2  ( 2 2  n M) ( -e-) i n  ( A ), TNFa i n  ( B) ,  o r  
s u p e r n a ta n ts  o f  A - N K  ce l l s  o r  CTL i n  ( C )  o n  g r o w t h  o f  P C I - 5 0  c e l l s .  T u m o r  c e l l s  
( 5 x l 03/ w e l l )  w e r e  cu l t u red w i t h  va r i o u s  d i l u t i o n s  o f  c y t o k i n e s  o r  s u p e r n a t a n ts 
p r e pa red  i n  96 -we l l  f l a t -bo t tom p l a tes .  O n  d a y  3 o f  c u l t u r e ,  g r o w t h  w a s  
m e a s u r e d  i n  MTT assays .  T h e  d a t a a re presen ted a s  t h e  pe rce n t  o f  c o n t r o l  ± S D  
o b t a i  n e d  f r o m  t r i p l i ca te  w e l l s .  S h o w n  a re resu  1 t s  o f  a re p re s e n  t a  t i  ve  e x p e r i m e n t  
o f  3 p e r f o rmed .  T h e  a s t e r i s k s  i n d i ca te a s i g n i f i ca n t  d i f f e r e n c e  ( p <0 .05 )  com­
pa red  wi th  co n t ro l  c u l t u res  ( m ed i u m  a l on e) .  
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